Acknowledgements
Cancer
CANCER
We thank Adenike Adesanya, Desiree Rainprecht, Dominik Stelzl, Edina Kepesidis, and Kathrin Stampf, for their support with the analyses. We would like to thank Emma Rennel Dickens and Mats Bergstrom (Olink AB, Uppsala, Sweden) for organizing and conducting the Olink®-based pilot analysis of plasma samples. We thank Martin Holcmann of the Institute of Cancer Research in Vienna for providing us with cell lines.